On November 8, 2016, the Supreme Court of Canada heard oral arguments and reserved its decision in AstraZeneca Canada Inc v Apotex Inc (SCC Case: 36654, esomeprazole – NEXIUM®, the Federal Court of Appeal decision previously reported in E-TIPS Newsletter here). Key issues raised at the hearing included whether a promised utility doctrine exists and, if yes, how to construe the promised utility. A webcast of the hearing can be accessed here.
Summary By: Junyi Chen
ETips Issue
16 11 16
Disclaimer: This Newsletter is intended to provide readers with general information on legal developments in the areas of e-commerce, information technology and intellectual property. It is not intended to be a complete statement of the law, nor is it intended to provide legal advice. No person should act or rely upon the information contained in this newsletter without seeking legal advice.
E-TIPS is a registered trade-mark of Deeth Williams Wall LLP.